Wall Street Experts
ver. ZuMIgo(08/25)
Strides Pharma Science Limited
Rachunek Zysków i Strat
Przychody TTM (mln): 44 103
EBIT TTM (mln): 6 650
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
Rok finansowy |
2004 |
2005 |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
Przychód (mln) |
4,485 |
5,237 |
7,430 |
7,443 |
10,203 |
13,048 |
16,958 |
25,116 |
8,919 |
11,315 |
27,512 |
26,564 |
27,965 |
21,083 |
26,567 |
32,512 |
30,221 |
36,077 |
40,511 |
Przychód Δ r/r |
0.0% |
16.8% |
41.9% |
0.2% |
37.1% |
27.9% |
30.0% |
48.1% |
-64.5% |
26.9% |
143.2% |
-3.4% |
5.3% |
-24.6% |
26.0% |
22.4% |
-7.0% |
19.4% |
12.3% |
Marża brutto |
49.4% |
54.0% |
48.2% |
43.9% |
42.5% |
42.0% |
42.9% |
49.7% |
44.9% |
50.5% |
45.3% |
49.1% |
49.1% |
46.8% |
55.4% |
56.7% |
47.6% |
52.9% |
35.5% |
EBIT (mln) |
847 |
944 |
1,085 |
989 |
4,842 |
1,038 |
3,224 |
4,349 |
853 |
1,749 |
2,876 |
4,035 |
2,562 |
855 |
1,886 |
3,149 |
-2,520 |
1,236 |
5,226 |
EBIT Δ r/r |
0.0% |
11.4% |
14.9% |
-8.8% |
389.8% |
-78.6% |
210.6% |
34.9% |
-80.4% |
105.0% |
64.4% |
40.3% |
-36.5% |
-66.6% |
120.6% |
66.9% |
-180.0% |
-149.1% |
322.8% |
EBIT (%) |
18.9% |
18.0% |
14.6% |
13.3% |
47.5% |
8.0% |
19.0% |
17.3% |
9.6% |
15.5% |
10.5% |
15.2% |
9.2% |
4.1% |
7.1% |
9.7% |
-8.3% |
3.4% |
12.9% |
Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
1,366 |
1,793 |
741 |
317 |
1,601 |
1,421 |
1,380 |
740 |
304 |
1,330 |
1,457 |
2,176 |
3,144 |
EBITDA (mln) |
1,061 |
1,180 |
1,410 |
1,355 |
5,247 |
1,531 |
3,862 |
5,392 |
1,948 |
2,390 |
5,108 |
7,248 |
4,490 |
2,348 |
3,956 |
6,632 |
-494 |
1,728 |
7,433 |
EBITDA(%) |
23.7% |
22.5% |
19.0% |
18.2% |
51.4% |
11.7% |
22.8% |
21.5% |
21.8% |
21.1% |
18.6% |
27.3% |
16.1% |
11.1% |
14.9% |
20.4% |
-1.6% |
4.8% |
18.3% |
Podatek (mln) |
124 |
34 |
174 |
171 |
108 |
219 |
452 |
386 |
111 |
532 |
425 |
634 |
57 |
-269 |
113 |
317 |
-1,783 |
-553 |
316 |
Zysk Netto (mln) |
440 |
486 |
402 |
-501 |
1,080 |
1,097 |
1,224 |
2,245 |
8,462 |
8,450 |
1,085 |
3,997 |
6,645 |
3,246 |
364 |
2,684 |
-4,602 |
-2,026 |
-1,248 |
Zysk netto Δ r/r |
0.0% |
10.4% |
-17.2% |
-224.6% |
-315.4% |
1.6% |
11.6% |
83.3% |
277.0% |
-0.1% |
-87.2% |
268.4% |
66.2% |
-51.1% |
-88.8% |
637.7% |
-271.4% |
-56.0% |
-38.4% |
Zysk netto (%) |
9.8% |
9.3% |
5.4% |
-6.7% |
10.6% |
8.4% |
7.2% |
8.9% |
94.9% |
74.7% |
3.9% |
15.0% |
23.8% |
15.4% |
1.4% |
8.3% |
-15.2% |
-5.6% |
-3.1% |
EPS |
13.13 |
13.43 |
10.55 |
-14.33 |
26.91 |
26.49 |
26.11 |
38.55 |
144.3 |
141.85 |
13.14 |
44.73 |
74.26 |
36.25 |
2.7 |
28.4 |
-51.28 |
-22.49 |
-13.65 |
EPS (rozwodnione) |
13.13 |
12.17 |
9.33 |
-10.59 |
24.7 |
19.67 |
24.56 |
38.32 |
131.85 |
141.27 |
13.06 |
44.64 |
74.24 |
36.24 |
2.7 |
28.37 |
-51.28 |
-22.49 |
-13.62 |
Ilośc akcji (mln) |
33 |
35 |
35 |
35 |
39 |
40 |
47 |
58 |
59 |
60 |
83 |
89 |
89 |
90 |
90 |
90 |
90 |
90 |
91 |
Ważona ilośc akcji (mln) |
33 |
39 |
41 |
47 |
53 |
55 |
50 |
59 |
63 |
60 |
83 |
90 |
90 |
90 |
90 |
90 |
90 |
90 |
92 |
Waluta |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |